Zobrazeno 1 - 10
of 158
pro vyhledávání: '"N, Duedari"'
Autor:
N. Duedari, P. Bierling, Catherine Cordonnier, Jean-Paul Vernant, M. Rodet, A. Pesce, Henri Rochant
Publikováno v:
Scandinavian Journal of Haematology. 33:215-220
3 aplastic patients with acute leukaemia, strongly HLA-immunized and refractory to platelet transfusions, received polyvalent gammaglobulin i.v. infusions (0.4 g/kg/d for 5 or 6 d) in association with daily random platelet transfusions. Platelet reco
Publikováno v:
Transfusion Clinique et Biologique. 16:12-20
Resume But de l’etude Le premier objectif etait de caracteriser la presence de l’hypotension arterielle (hTA) dans les effets indesirables receveurs (EIR) et d’y evaluer la part de la reaction transfusionnelle hypotensive « isolee », un diagn
Publikováno v:
Transfusion Clinique et Biologique. 12:295-300
Resume La reglementation prevoit en France que les etablissements de sante recueillent et conservent toutes les informations relatives a l'hemovigilance et notamment celles portant sur les examens pre- et post-transfusionnels pratiques pour les patie
Publikováno v:
Transfusion Clinique et Biologique. 11:153-160
Resume Le depistage VIH et VHC chez les receveurs de produits sanguins labiles a ete recommande en 1996 en France par circulaire ministerielle. Applique en pretransfusionnel et dans les quatre mois suivants, il vise a depister les contaminations tran
Autor:
Cordonnier C, Lionel Desforges, Bruno Roche, J. P. Vernant, N. Duedari, Norol F, M. Kuentz, Saint Marc Girardin Mf
Publikováno v:
Revue Française de Transfusion et d'Hémobiologie. 36:499-507
Post-transfusion hepatitis C incidence was studied in a series of patients with bone marrow allograft. The risk of HCV seroconversion was evaluated according to the date of grafting and the screening tests carried out in blood donors at this time. An
Publikováno v:
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine. 16(1)
The first aim of this study was to confirm the presence of hypotension blood transfusion reactions and to assess the part of hypotension as a principal event, as defined by the literature but not characterized in French haemovigilance data. As well,
Publikováno v:
Annales francaises d'anesthesie et de reanimation. 27(2)
The use of preoperative autologous blood transfusion has dramatically decreased in France. The aim of this study was to evaluate the evolution of practice both of autologous and homologous Red Blood Cells (RBC) concentrates transfusion between 2002 a
Publikováno v:
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine. 12(4)
In France, data collection related to blood recipient's viral infectious disease markers pre and post-transfusion is a legal requirement for hospitals. Our study aimed to evaluate the actual modalities of this extensive screening in 2001, six years a
Publikováno v:
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine. 11(3)
Screening of labile blood products recipients for HIV and HCV has been performed in France since a government recommendation was issued in 1996. It has been designed to get transfusion related contamination of recipients through pre- and post-transfu
Autor:
F, Beaujean, F, Bernaudin, M, Kuentz, S, Lemerle, C, Cordonnier, C, Le Forestier, P, Reinert, N, Duedari, M, Brandely, J P, Vernant
Publikováno v:
Bone marrow transplantation. 15(5)
Disease recurrence remains the major problem in autologous bone marrow transplantation (BMT) for hematologic malignancies. To improve the therapeutic efficiency of autologous BMT, we investigated the use of autologous marrow activated in vitro with i